Fundraising Fox
Ethyrealbio
Cambridge, US · 14 employees on LinkedIn · 3 known investors
Find your way into Ethyrealbio
Sign up to see every warm intro you have to Ethyrealbio
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Ethyrealbio team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Ethyreal Bio is a biopharmaceutical company developing medicines for people with Thyroid Eye Disease and Graves' Disease. It focuses on antibody and other therapeutic programs in the endocrine/immunology space.
Founders & leadership
NK
Niranjan KameswaranChief Executive Officer
SH
Stephen HuangSenior Vice President, Head of Clinical DevelopmentStephen Huang is Senior Vice President of Clinical Development at Ethyreal Bio, a biopharmaceutical company developing treatments for thyroid eye disease and Graves' disease. A board-certified pediatric endocrinologist and physician-scientist, he previously served as an Associate Professor of Pediatrics at Harvard Medical School, where he conducted NIH-funded research and founded the Boston Children's Hospital Thyroid Center, and brings over 25 years of clinical development experience across antibody therapeutics, gene editing, and small molecule programs in rare and common diseases.
Board
SR
Investors · 3
Atlas Venture✓ confirmed by EthyrealbioCambridge · $500K – $1M
How we know: Atlas Venture's portfolio page · the company's own site · Not right? Tell us
Frequently asked questions
- What does Ethyrealbio do?
- Ethyreal Bio is a biopharmaceutical company developing medicines for people with Thyroid Eye Disease and Graves' Disease. It focuses on antibody and other therapeutic programs in the endocrine/immunology space.
- Who are Ethyrealbio's investors?
- Ethyrealbio's investors include Atlas Venture, Avoro Capital Advisors, Medicxi.
- Where is Ethyrealbio headquartered?
- Ethyrealbio is headquartered in Cambridge, US.